QIAGEN N.V.: QIAGEN Expands QuantiFERON Portfolio in the Fight Against TB
QuantiFERON franchise benefits from new applications, products and automation options, building on strengths in tuberculosis detection while addressing new disease targets QuantiFERON SARS-CoV-2